Drug intelligence / Profile preview

COVID Rehab Formula

Development stage: Phase 2
Administration: Oral

Overview

COVID Rehab Formula (CRF) is a traditional Chinese medicine formulation designed to treat residual symptoms in patients recovering from COVID-19. It combines two traditional Chinese medicine formulations: Liujunzhi Decoction (LJZD) and Shashen Maidong Decoction (SSMDD). The formula consists of multiple herbs including Ginseng Radix Et Rhizoma, Atractylodis Macrocephalae, Rhizoma Poria, and others, with additional herbs added based on specific symptoms. It is administered as granules dissolved in hot water, taken twice daily after meals.

Other names: COVID-19 Rehab FormulaCOVID19 Rehab FormulaCOVID 19 Rehab FormulaCOVID Rehabilitation FormulaChinese Medicine for Residual COVID-19 Symptoms

Beyond the preview

Go deeper on COVID Rehab Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on COVID Rehab Formula.

Explore the full profile